Merck & Co., Inc.: KYMR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Merck & Co., Inc. on KYMR, newest first. How the timeline and the estimate are built.
Merck & Co., Inc. held 772,165 KYMR shares at 2026-06-30 per its 13F-HR filed 2026-08-07.
the latest 13F is the newest step
- period ended2026-06-3013F 772,165 sharesChange vs previous 13F 0 shares
16.82% of the 13F portfolio, value $88,544,161.
13F-HR 0000310158-26-000210 filed by Merck & Co., Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 772,165 sharesChange vs previous 13F 0 shares
18.4% of the 13F portfolio, value $64,313,623.
13F-HR 0000310158-26-000141 filed by Merck & Co., Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 772,165 sharesChange vs previous 13F 0 shares
21.75% of the 13F portfolio, value $60,082,159.
13F-HR 0000310158-26-000055 filed by Merck & Co., Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 772,165 sharesChange vs previous 13F 0 shares
19.17% of the 13F portfolio, value $43,704,539.
13F-HR 0000310158-25-000063 filed by Merck & Co., Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 772,165 sharesChange vs previous 13F 0 shares
15.63% of the 13F portfolio, value $33,697,281.
13F-HR 0001691304-25-000005 filed by Merck & Co., Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 772,165 sharesChange vs previous 13F 0 shares
12.86% of the 13F portfolio, value $21,134,156.
13F-HR 0000064978-25-000005 filed by Merck & Co., Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 772,165 sharesChange vs previous 13F not available
12.04% of the 13F portfolio, value $31,064,198.
13F-HR 0000895345-25-000055 filed by Merck & Co., Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).